Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Carlos, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,038 SEC EDGAR filings since 29 Jan 2008

SEC filing history

Showing 551-575 of 1,000 matching filings.

Per page
25
Current page
23
424B5 File 333-222340

FINAL PROSPECTUS SUPPLEMENT

Filing date
25 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85384

SC 13G filing

Filing date
25 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-222340

424B5

Filing date
24 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
24 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-222340

EFFECT filing

Filing date
19 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
17 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-212373

424B3

Filing date
09 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jan 2018
Reporting date
29 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
08 Jan 2018
Reporting date
08 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-222340

S-3

Filing date
28 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
13 Dec 2017
Reporting date
13 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-214073

424B3

Filing date
01 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
13 Nov 2017
Reporting date
06 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
31 Oct 2017
Reporting date
31 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-214073

424B3

Filing date
26 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
26 Oct 2017
Reporting date
26 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
20 Oct 2017
Reporting date
20 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36860

CT ORDER filing

Filing date
28 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
26 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

8-K

Filing date
21 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215320

FINAL PROSPECTUS SUPPLEMENT

Filing date
21 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215320

424B5

Filing date
19 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36860

FORM 8-K

Filing date
15 Sep 2017
Reporting date
14 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .